Renal tissue oxygenation monitoring using near-infrared spectroscopy in late preterm and term neonates at risk for acute kidney injury
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2024 - 2028
Project Lead
Nivedita Kamath
Authors
Nivedita Kamath
Project Status
ongoing
Project Type
ICMR extramural small grant